Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Jul;72(1):185–188. doi: 10.1038/bjc.1995.300

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients.

S J Wigmore 1, J S Falconer 1, C E Plester 1, J A Ross 1, J P Maingay 1, D C Carter 1, K C Fearon 1
PMCID: PMC2034153  PMID: 7541236

Abstract

The aim of this study was to investigate the effect of the cyclo-oxygenase inhibitor ibuprofen on the acute-phase protein response and resting energy expenditure (REE) of weight-losing patients with pancreatic cancer. Patients with irresectable pancreatic cancer (n = 16) were treated with either ibuprofen (1200 mg day-1 for 7 days (n = 10) or placebo (n = 6). A group of 17 age-related non-cancer subjects were also studied. Indirect calorimetry, anthropometry, multifrequency bioelectrical impedence analysis and serum C-reactive protein (CRP) estimation were performed immediately before and after treatment. Before treatment, total REE was significantly elevated in the pancreatic cancer patients compared with healthy controls (1499 +/- 71 vs 1377 +/- 58 kcal) (P < 0.02). Following treatment the mean REE of the ibuprofen group fell significantly (1386 +/- 89 kcal) compared with pretreatment values (1468 +/- 99 kcal) (P < 0.02), whereas no change was observed in the placebo group. Serum CRP concentration was also reduced in the ibuprofen-treated group (pre-ibuprofen, 51 mg l-1; post-ibuprofen, 29 mg l-1; P < 0.05). These results suggest that ibuprofen may have a role in abrogating the catabolic processes which contribute to weight loss in patients with pancreatic cancer.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calman K. C. Malignancy. Cancer cachexia. Br J Hosp Med. 1982 Jan;27(1):28-9, 33-4. [PubMed] [Google Scholar]
  2. Cush J. J., Lipsky P. E., Postlethwaite A. E., Schrohenloher R. E., Saway A., Koopman W. J. Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum. 1990 Jan;33(1):19–28. doi: 10.1002/art.1780330103. [DOI] [PubMed] [Google Scholar]
  3. Dinarello C. A., Wolff S. M. Molecular basis of fever in humans. Am J Med. 1982 May;72(5):799–819. doi: 10.1016/0002-9343(82)90548-4. [DOI] [PubMed] [Google Scholar]
  4. Durum S. K., Schmidt J. A., Oppenheim J. J. Interleukin 1: an immunological perspective. Annu Rev Immunol. 1985;3:263–287. doi: 10.1146/annurev.iy.03.040185.001403. [DOI] [PubMed] [Google Scholar]
  5. Falconer J. S., Fearon K. C., Plester C. E., Ross J. A., Carter D. C. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 1994 Apr;219(4):325–331. doi: 10.1097/00000658-199404000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fearon K. C., McMillan D. C., Preston T., Winstanley F. P., Cruickshank A. M., Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg. 1991 Jan;213(1):26–31. doi: 10.1097/00000658-199101000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fearon K. C. The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc. 1992 Aug;51(2):251–265. doi: 10.1079/pns19920036. [DOI] [PubMed] [Google Scholar]
  8. Hannan W. J., Cowen S. J., Fearon K. C., Plester C. E., Falconer J. S., Richardson R. A. Evaluation of multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci (Lond) 1994 Apr;86(4):479–485. doi: 10.1042/cs0860479. [DOI] [PubMed] [Google Scholar]
  9. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb 1;265(3):621–636. doi: 10.1042/bj2650621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kunkel S. L., Chensue S. W., Phan S. H. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol. 1986 Jan;136(1):186–192. [PubMed] [Google Scholar]
  11. Makita K., Nunn J. F., Royston B. Evaluation of metabolic measuring instruments for use in critically ill patients. Crit Care Med. 1990 Jun;18(6):638–644. doi: 10.1097/00003246-199006000-00013. [DOI] [PubMed] [Google Scholar]
  12. Martich G. D., Danner R. L., Ceska M., Suffredini A. F. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med. 1991 Apr 1;173(4):1021–1024. doi: 10.1084/jem.173.4.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Reeds P. J., Fjeld C. R., Jahoor F. Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J Nutr. 1994 Jun;124(6):906–910. doi: 10.1093/jn/124.6.906. [DOI] [PubMed] [Google Scholar]
  14. Spinas G. A., Bloesch D., Keller U., Zimmerli W., Cammisuli S. Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia. J Infect Dis. 1991 Jan;163(1):89–95. doi: 10.1093/infdis/163.1.89. [DOI] [PubMed] [Google Scholar]
  15. Starnes H. F., Jr, Warren R. S., Jeevanandam M., Gabrilove J. L., Larchian W., Oettgen H. F., Brennan M. F. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest. 1988 Oct;82(4):1321–1325. doi: 10.1172/JCI113733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Strassmann G., Fong M., Freter C. E., Windsor S., D'Alessandro F., Nordan R. P. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J Clin Invest. 1993 Nov;92(5):2152–2159. doi: 10.1172/JCI116816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tracey K. J., Wei H., Manogue K. R., Fong Y., Hesse D. G., Nguyen H. T., Kuo G. C., Beutler B., Cotran R. S., Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988 Mar 1;167(3):1211–1227. doi: 10.1084/jem.167.3.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wallace B. H., Caldwell F. T., Jr, Cone J. B. Ibuprofen lowers body temperature and metabolic rate of humans with burn injury. J Trauma. 1992 Feb;32(2):154–157. doi: 10.1097/00005373-199202000-00007. [DOI] [PubMed] [Google Scholar]
  19. West M. A., Manthei R., Bubrick M. P. Autoregulation of hepatic macrophage activation in sepsis. J Trauma. 1993 Apr;34(4):473–480. doi: 10.1097/00005373-199304000-00001. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES